Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

12-dose Isoniazid/Rifapentine Regimen for Latent TB Infection Treatment

Fact Sheet
12-dose Isoniazid/Rifapentine Regimen for Latent TB Infection Treatment

This fact sheet provides an overview of the 12-dose regimen for treating latent TB infection.

Author:

California Department of Public Health, California Department of Public Health, Tuberculosis Control Branch, CDHS DCDC VRDL

Topic:

Treatment - Latent TB infection (Inactive TB)

Language:

English

View Webpage

Related Materials

12-Dose Regimen for Latent TB Infection

This brochure was developed for clinicians to use with patients while discussing the 12-dose regimen. The brochure contains information on latent TB infection, the 12-dose regimen, treatment schedules, and adverse events. There is space on this brochure to write in treatment schedules and clinic/office contact information.

The 12-Dose Regimen for Latent Tuberculosis (TB) Infection

This information sheet discusses the once-a-week 12-week treatment of rifapentine and isoniazid for latent TB infection (LTBI). It explains LTBI, why it is necessary to treat it, the treatment plan and how it is managed, and a chart for tracking. It also includes hints on how to take the medicine including eating before taking it and avoiding alcohol, and describes normal side effects and possible problems including which signs and symptoms require you to call the doctor or nurse and what to do when taking a dose of medicine in the absence of medical staff.

Information Sheet

12-Dose Regimen for Latent TB Infection - Patient Education Materials

The materials were developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The materials include a patient education brochure, medication tracker, and symptom checklist. The brochure contains information on latent TB infection, the 12-dose regimen, and adverse events. The medication tracker includes space to write treatment schedules, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 12-dose regimen.

Brochure

Global resources for the prevention,
management, and elimination of TB.